SELE and inflammatory bowel disease: Dual-selectin-targeted USMI has previously been used to differentiate different disease activities of inflammation and to assess treatment effects, and USMI findings were validated using standard references of ex vivo histology and P- and E-selectin expression in various rodent and swine models of IBD [17,19,20,21].